Key Takeaways
- Apple (AAPL) unveiled Siri AI and new image generation tools at WWDC 2026, while Software Chief Craig Federighi explicitly denied that Apple Intelligence is built on Google Search.
- Eli Lilly (LLY) announced that its oral GLP-1 Foundayo outperformed oral semaglutide in pivotal trials, achieving a 73.6% greater weight loss at the 17.2mg dose.
- Brent Crude prices climbed 1.25% to settle at $94.25/bbl, driven by escalating geopolitical rhetoric from Iran and the IRGC.
- Ukrainian President Zelensky held high-level calls with Trump envoys Steve Witkoff and Jared Kushner to discuss ongoing peace efforts.
- A federal judge struck down the $100,000 H-1B visa fee, prompting an immediate appeal from the White House.
Apple’s AI Roadmap and WWDC Highlights
At the 2026 Worldwide Developers Conference (WWDC), Apple (AAPL) announced the beta launch of Siri AI, a major overhaul of its virtual assistant scheduled for later this year. The new system features on-screen awareness, personal context understanding, and a dedicated app for revisiting AI-driven conversations. Apple also introduced Home app intelligence for advanced camera clip analysis and photo-realistic image generation that integrates directly with a user’s personal photo library.
Addressing rumors of a search partnership, Apple Software Chief Craig Federighi clarified that Apple Intelligence is not built on Google Search (GOOGL). While the company has explored foundation model collaborations, Federighi emphasized that Apple’s architecture is designed for on-device privacy and independent reasoning. Despite the announcements, shares of Apple saw a slight decline as the company noted some AI features would not be immediately available in the Chinese market.
Eli Lilly’s Foundayo Dominates Oral GLP-1 Trials
Eli Lilly (LLY) reported landmark results from its ACHIEVE phase 3 trials for Foundayo (orforglipron), its small-molecule oral GLP-1. In a head-to-head study against oral semaglutide, Foundayo 17.2mg demonstrated a 57.1% greater A1C reduction and 73.6% greater weight loss. Unlike competing oral treatments, Foundayo does not require strict food or water restrictions, a factor analysts believe will secure its market dominance.
The company confirmed it is on track for an FDA submission by the end of Q2 2026. Additional data from the ATTAIN trials showed the drug is also highly effective for weight management in women across all stages of menopause. With a market capitalization exceeding $1 trillion, Lilly continues to lead the cardiometabolic sector, positioning Foundayo as a "future blockbuster" alongside Zepbound.
Energy Markets and Geopolitical Tensions
Energy prices rose on Monday as geopolitical risks intensified in the Middle East. Brent Crude settled up 1.25% at $94.25/bbl, while US Crude (WTI) gained 0.84% to close at $91.30/bbl. The price action followed a vow from IRGC Commander Qa’ani to establish a "resistance security belt" spanning from the Strait of Hormuz to the Bab al-Mandeb, potentially threatening critical global shipping lanes.
Simultaneously, an Iranian official told CNN that Tehran has "no objection" to resuming talks with the United States, but demanded a fundamental "change in American behaviour." This diplomatic signaling comes as President Zelensky initiated contact with Donald Trump’s envoys, Steve Witkoff and Jared Kushner, to discuss peace terms. Sources indicate the call focused on security guarantees and economic recovery as part of a proposed peace framework.
Global Markets and Policy Developments
In the commodities sector, Vale (VALE) CEO Gustavo Pimenta projected that India will double its steel output within the next decade. Pimenta noted that India’s infrastructure boom is offsetting stagnant demand from China, with Vale aiming to significantly increase iron ore shipments to the South Asian nation. Meanwhile, the Peru Sol strengthened 1.15%, closing at 3.4200/3.4340 per dollar.
On the domestic front, the White House announced it will appeal a federal court ruling that struck down a controversial $100,000 H-1B visa fee. The fee, which was intended to prioritize high-paid foreign workers, was deemed an "unauthorized tax" by a judge in Boston. Additionally, Democratic Senators have requested an Inspector General probe into Transportation Secretary Duffy regarding a "corporate-donor-funded road trip," adding to the political friction in Washington.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.